Lung cancer and prostate cancer mortality was not significantly improved with metformin, although the HRs did show an overall trend toward reduced mortality.
← all excerpts
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality.
1
—
—